🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

ATNM ATNM

Company Profile ↓
$0.75
-54.90% 1Y
P/E-0.69
52W High$1.79
52W Low$0.75
EPS (TTM)$-1.09

Company Overview

ATNM (ATNM) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Trailing 12 Months Year-on-year growth — revenue +11.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-
1 Year:11.11%

Stock Price Performance

1 Year:-54.90%
6 Months:-37.61%
3 Months:-40.58%
1 Month:-28.70%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
$0.75 $1.79
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)24.95 · Oversold
Price Performance
1M-28.70%
3M-40.58%
6M-37.61%
1Y-54.90%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 58.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).
  • RSI at 25 suggests oversold conditions.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.69
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
11.11%
Earnings (YoY)
-

Profitability & Returns

ROCE
-82.74%
ROE
-
ROA
-65.45%
Profit Margin
-
Op Margin
-
Gross Margin
0.00%
EPS (Latest Qtr)
$-0.18
EPS (TTM)
$-1.09

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$45.44M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
2.35%
Chg in Prom Hold
-
FII / Inst Holding
20.61%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$90.00K
EBITDA
-
Free Cash Flow
$-24.68M
Operating Cash Flow
$-24.58M
Shares Outstanding
-
Gross Margin
0.00%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------------------622.00K266.00K233.00K940.00K45.00K45.00K--------90.00K-
Operating Income -2.02M-1.48M-1.61M-4.14M-4.42M-7.04M-7.87M-7.40M-4.64M-6.00M-6.92M-7.10M-7.81M-7.20M-6.70M-6.35M-4.91M-6.20M-5.70M-5.09M-6.65M-5.68M-4.66M-5.61M-5.37M-5.08M-6.47M-5.16M-7.85M-9.80M-11.58M-15.64M-14.35M-9.60M-12.42M-12.60M-16.64M-7.50M-5.69M-5.90M
Net Income -689.03K-2.78M-1.42M-16.70M3.52M-6.08M-3.07M-7.46M-3.95M-4.40M-6.62M-6.60M-8.06M-7.05M-6.32M-6.32M-4.86M-6.15M-5.67M-5.03M-6.60M-5.67M-4.62M-5.54M-5.32M-5.02M-6.42M-5.13M-7.77M-9.47M-11.04M-15.18M-13.28M-8.67M-11.35M-11.57M-15.94M-6.88M-5.13M-5.52M
Diluted EPS --0.13--0.10---0.20-0.10--0.15-0.14--------------0.25-0.30-0.23-0.33-0.38-0.43-0.58-0.49-0.31-0.38-0.37-0.51-0.22-0.16-0.18
R&D Expense 1.09M509.26K778.23K1.59M2.13M4.14M4.05M3.84M2.83M3.77M4.15M5.69M4.57M4.45M5.03M4.47M3.33M4.23M4.34M4.01M4.83M4.15M3.51M3.79M4.28M3.63M4.71M4.37M4.66M6.77M7.85M11.08M11.62M6.63M8.82M9.77M7.70M4.88M4.25M4.20M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ---------00---------1.14M1.03M81.00K-90.00K
Gross Profit ---------00--------------
Operating Income ----------26.05K-3.28M-7.95M-6.59M-22.48M-24.83M-26.85M-26.91M-23.83M-22.07M-22.39M-24.96M-34.10M-51.92M-42.12M-36.25M
Net Income -5.09M-3.19M-3.53M-5.73M-4.58M-6.05M-5.62M-5.57M-3.43M-467.27K-3.44M-8.36M-10.77M-24.69M-21.03M-24.32M-26.60M-23.65M-21.90M-22.21M-24.77M-33.02M-48.82M-38.24M-33.89M
Diluted EPS ---------------------1.20-1.37-1.83-1.27-1.09
R&D Expense ----------323.79K3.44M3.11M12.27M13.50M17.83M17.72M17.09M16.55M16.09M18.03M23.14M38.67M30.05M21.12M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2000Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ----------1506.20M5.79M5.77M7.57M26.59M22.53M18.34M14.89M11.67M66.40M80.39M114.19M81.44M76.90M51.77M
Total Equity 1.11M-1.73M-1.68M1.57M439.12K74.28K1.82M3.46M4.16M845.16K399.06K992.01K1.15M-1.56M-1.92M21.97M18.01M13.67M8.81M5.64M61.32M73.55M66.48M36.38M32.76M7.83M
Cash & Equivalents ---------2.12K196.13K5.70M5.62M5.53M6.71M25.64M20.52M17.40M13.67M9.25M63.56M77.83M108.91M76.68M72.90M48.00M
Total Liabilities ----------94.77K84.48K4.64M7.33M9.49M4.61M4.52M4.67M6.08M6.03M5.08M6.84M47.71M45.07M44.14M43.94M
Current Liabilities ----------36.06K5.21M4.64M7.33M9.49M4.61M4.52M4.67M6.06M5.34M4.77M6.84M10.63M8.49M8.15M7.97M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 7.83K-517.59K-5.21M-6.29M-14.35M-18.54M-20.79M-21.55M-20.57M-21.46M-21.62M-20.87M8.64M-47.34M-33.07M-24.58M
Investing Cash Flow 00-2.36K-16.59K-186.42K-47.79K-109.82K-24.74K-96.09K-64.00K-253.00K-133.00K-366.00K-153.00K-11.00K-104.00K
Financing Cash Flow -9.81K6.03M5.13M6.22M15.71M37.53M15.78M18.81M16.98M17.11M76.18M35.22M23.11M14.87M29.32M-217.00K
Capital Expenditure ---2.36K-16.59K-151.69K-47.79K-59.96K-24.74K-96.09K-64.00K-253.00K-133.00K-366.00K-153.00K-11.00K-104.00K
Free Cash Flow ---5.22M-6.31M-14.50M-18.59M-20.85M-21.58M-20.67M-21.53M-21.87M-21.00M8.28M-47.49M-33.08M-24.68M

Ratios (Annual)

Figures in %.

Metric Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------------------
Operating Margin % ---------------------2,182.2%-3,311.1%-64,098.8%--40,274.4%
Net Margin % ---------------------2,165.6%-3,205.5%-60,269.1%--37,652.2%
ROE % 293.8%190.6%-224.4%-1,306.0%-6,166.6%-331.9%-162.4%-134.0%-405.4%-117.1%-347.3%-729.8%690.8%1,284.1%-95.7%-135.1%-194.6%-268.4%-388.0%-36.2%-33.7%-49.7%-134.2%-116.7%-432.6%
ROCE % ---------72.5%-331.0%-693.7%422.7%1,169.3%-113.0%-149.1%-196.8%-270.0%-348.9%-36.3%-33.9%-32.9%-71.2%-61.3%-82.7%

Shareholding Pattern

Insiders
2.35%
Institutions
20.61%
Public Float
21.10%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ATNM

Google News Wed, 03 Jun 2026

Actinium Presents New ATNM-400 Data in KRAS and EGFR Mutant Models at SNMMI 2026 Supporting a Mutation-Agnostic Opportunity In Non-Small Cell Lung Cancer - PR Newswire

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxPakd6Wml2ampBRVdPYjBBV25sajFleExBSkptaHA1QUgxUGFUcnVjcnVJR0lramtsc3lqbDd0Q3YyeFFVNXVZYVA2THFDVXRpdUczZ0VfMTJPTDIyY2tFWUVBQm5hZEs0VlljVFZPWEZmSVgtZm0zelZRanU0dUFSM09aa3poQ25VMWhRQ2…

Google News Fri, 10 Jul 2026

ATNM Should I Buy - Intellectia AI

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1kNjljWFRLcXRGLUI0ZFZkS3dzcG9IVExBTE9FTTNsX0VwdVFiYXVabmRqdnlHOGFWeENFZExaOFN1MXZ2RHFtSzR1TGpaQm4zNVdnOUJOaklXVTVEVlE?oc=5" target="_blank">ATNM Should I Buy</a>&nbsp;&nbsp;<font c…

Google News Mon, 20 Oct 2025

ATNM Stock Price and Chart — AMEX:ATNM - TradingView

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1lLW5XMmVBVjRpNDBHZU1hWjRid1Y2S01QUFRIazdzekZ0S01obW9XWXlOaGN0Y0x5QkNkQmFtVFZsUnpMRkh6bEM3cnp1OVh3T1dQeU04amk3dw?oc=5" target="_blank">ATNM Stock Price and Chart — AMEX:ATNM</a>&nb…

Google News Mon, 20 Apr 2026

SLS Vs ATNM: Which Cancer Stock Has Bigger Upside Ahead Of Fresh Data Reveal? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQSzF0LXF1azRaT2R6Q2w2dHg0Tkg2UXJMUGRoZE5TUWJSdUJvaUJkR0NLWDlWaXROUThwY05rdXZjZGhaQ2tGYmp0Q3pYdzFrMkJyNURNZTJvQWlTa1g2N291cTZSa2ZmR1JtMjA3RXhMYnU2SWtsbHN4S184UzZXTHNDZjh2RngwQjcyUG…

Google News Mon, 17 Nov 2025

The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxON1dudkhCY0VWajFxVzZGSlRPeWxEVXdJdTR3X1NETHo0aG5LcVVlX0FUNUxhaUp1bzU1NlNsUGc1YlRDOHNYanpRM0N5dTB1S2JqeWFqVTRUT195S3ZEWFc4VHVRNFgyc095WjFuWGFrTGxWWHRfZDVLRkp2cS1mRWFMTFh5VEQ1ZVp3Rz…

Google News Fri, 29 May 2026

Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice - PR Newswire

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxPWTZFa21UQXZKdFRKenBmQmZDdWNEYTFOOS1Dbk1rWlNlSEFsYkZ6NGo2bGt0clI5R2toeHBxOWdMaGdCWW9zZF8yZHFiTWRabVlGVDdSNmRIMk9zcDFKMTNKQl9PbGlDc3RXV0VNeW9ObUtpYjk1YWtjWjFKaHI4RERTZy16TWw2RXNNb1…

ATNM — Frequently Asked Questions

What is the current share price of ATNM?

As of 2026-08-05 17:25 PDT, ATNM trades at $0.75 on NASDAQ/NYSE. Its 52-week range is $0.75 to $1.79.

What is the P/E ratio of ATNM?

ATNM trades at a trailing price-to-earnings (P/E) ratio of -0.69.

Is ATNM a good stock to buy?

This page provides a data-driven analysis of ATNM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space